These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1801704)

  • 1. Proteolysis of defensive proteins in peritonitis exudate: pathobiochemical aspects and therapeutical approach.
    Billing A; Fröhlich D; Assfalg-Machleidt I; Machleidt W; Jochum M
    Biomed Biochim Acta; 1991; 50(4-6):399-402. PubMed ID: 1801704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakdown of C3 complement and IgG in peritonitis exudate--pathophysiological aspects and therapeutic approach.
    Billing A; Kortmann H; Fröhlich D; Jochum M
    Prog Clin Biol Res; 1989; 308():527-33. PubMed ID: 2780713
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteolytic destruction of functional proteins by phagocytes in human peritonitis.
    Jochum M; Billing AG; Fröhlich D; Schildberg FW; MacHleidt W; Cheronis JC; Gippner-Steppert C; Fritz H
    Eur J Clin Invest; 1999 Mar; 29(3):246-55. PubMed ID: 10202382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insufficiency of intra-abdominal immunity to infection in purulent peritonitis--sequela of disordered foreign body opsonization].
    Billing A; Fröhlich D; Kortmann H; Jochum M
    Klin Wochenschr; 1989 Mar; 67(6):349-56. PubMed ID: 2540381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local serum application: restoration of sufficient host defense in human peritonitis.
    Billing AG; Fröhlich D; Konecny G; Schildberg FW; Machleidt W; Fritz H; Jochum M
    Eur J Clin Invest; 1994 Jan; 24(1):28-35. PubMed ID: 8187805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient phagocytosis secondary to proteolytic breakdown of opsonins in peritonitis exudate.
    Billing A; Fröhlich D; Jochum M; Kortmann H
    Adv Exp Med Biol; 1988; 240():441-8. PubMed ID: 2854362
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agents.
    Jochum M; White J; Duswald KH; Inthorn D; Welter H; Fritz H
    Behring Inst Mitt; 1986 Feb; (79):121-30. PubMed ID: 3521575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma.
    Isidoro C; Démoz M; De Stefanis D; Baccino FM; Bonelli G
    Invasion Metastasis; 1995; 15(3-4):116-24. PubMed ID: 8621267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis.
    Runyon BA
    Hepatology; 1988; 8(3):632-5. PubMed ID: 3371881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement and immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis.
    Yildirim B; Sezgin N; Sari R; Sevinc A; Hilmioglu F
    South Med J; 2002 Oct; 95(10):1158-62. PubMed ID: 12425501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regulation of neoplasm-specific cathepsin B by cysteine-protease inhibitors present in cancerous exudates].
    Keppler D; Pagano M; Dalet-Fumeron V; Engler R
    C R Acad Sci III; 1985; 300(13):471-4. PubMed ID: 3924358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(6):551-6. PubMed ID: 3126457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.
    Bergenfeldt M; Ohlsson K
    Gastroenterol Jpn; 1993 Oct; 28(5):687-98. PubMed ID: 8224620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritonitis prevention in CAPD.
    Carozzi S; Lamperi S
    Clin Nephrol; 1988; 30 Suppl 1():S45-8. PubMed ID: 3141093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonic activity of human ascitic fluid.
    Reider H; Ramadori G; Meyer zum Büschenfelde KH
    Hepatology; 1986; 6(3):545-6. PubMed ID: 3710440
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of C3 and IgG proteolysis enhances phagocytosis of Porphyromonas gingivalis.
    Cutler CW; Arnold RR; Schenkein HA
    J Immunol; 1993 Dec; 151(12):7016-29. PubMed ID: 8258706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concentration and properties of albumin in the serum and peritoneal exudate in patients with peritonitis].
    Rodoman GV; Shalaeva TI; Dobretsov GE; Korotaev AL
    Vopr Med Khim; 1999; 45(5):407-15. PubMed ID: 10635535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein degradation in cell cultures: general considerations on mechanisms and regulation.
    Dean RT
    Fed Proc; 1980 Jan; 39(1):15-9. PubMed ID: 6985868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.